AAAAAA
Results: 1-25/44
A STUDY OF FILGRASTIM (RG-CSF) PRIMING OF ETOPOSIDE CISPLATIN IN ADVANCED NONSMALL CELL LUNG-CANCER/
Authors:
MEHDI SA
PERRY MC
HERNDON JE
CRAWFORD J
YOUNG R
GRAZIANO SL
Citation: Sa. Mehdi et al., A STUDY OF FILGRASTIM (RG-CSF) PRIMING OF ETOPOSIDE CISPLATIN IN ADVANCED NONSMALL CELL LUNG-CANCER/, Journal of interferon & cytokine research, 18(8), 1998, pp. 623-627
Authors:
PERRY MC
HERNDON JE
EATON WL
GREEN MR
Citation: Mc. Perry et al., THORACIC RADIATION-THERAPY ADDED TO CHEMOTHERAPY FOR SMALL-CELL LUNG-CANCER - AN UPDATE OF CANCER AND LEUKEMIA GROUP-B STUDY-8083, Journal of clinical oncology, 16(7), 1998, pp. 2466-2467
Authors:
AHLES TA
SILBERFARB PM
HERNDON J
MAURER LH
KORNBLITH AB
AISNER J
PERRY MC
EATON WL
ZACHARSKI LL
GREEN MR
HOLLAND JC
Citation: Ta. Ahles et al., PSYCHOLOGIC AND NEUROPSYCHOLOGIC FUNCTIONING OF PATIENTS WITH LIMITEDSMALL-CELL LUNG-CANCER TREATED WITH CHEMOTHERAPY AND RADIATION-THERAPY WITH OR WITHOUT WARFARIN - A STUDY BY THE CANCER AND LEUKEMIA GROUP-B, Journal of clinical oncology, 16(5), 1998, pp. 1954-1960
Authors:
PERRY MC
Citation: Mc. Perry, INTRODUCTION - PREVENTING THE TOXICITY OF CHEMOTHERAPY, Seminars in oncology, 25(5), 1998, pp. 521-521
Authors:
BADYAL K
MCWHINNIE WR
HOMER J
PERRY MC
Citation: K. Badyal et al., THE SYNTHESIS AND NMR SPECTROSCOPIC EXAMINATION OF COORDINATION-COMPLEXES OF 2-TELLURAINDANE WITH RHODIUM, Journal of organometallic chemistry, 555(2), 1998, pp. 279-284
Authors:
HOMER J
PERRY MC
PALFREYMAN SA
Citation: J. Homer et al., ACCELERATED RELAXATION OF SENSITIVE NUCLEI FOR ENHANCEMENT OF SIGNAL-TO-NOISE WITH TIME, Journal of magnetic resonance [1997], 125(1), 1997, pp. 20-27
Authors:
DORR VJ
PERRY MC
Citation: Vj. Dorr et Mc. Perry, ADJUVANT THERAPY FOR STAGE-I AND STAGE-II NONSMALL CELL LUNG-CANCER, Hematology/oncology clinics of North America, 11(2), 1997, pp. 267
Authors:
MAURER LH
HERNDON JE
HOLLIS DR
AISNER J
CAREY RW
SKARIN AT
PERRY MC
EATON WL
ZACHARSKI LL
HAMMOND S
GREEN MR
Citation: Lh. Maurer et al., RANDOMIZED TRIAL OF CHEMOTHERAPY AND RADIATION-THERAPY WITH OR WITHOUT WARFARIN FOR LIMITED-STAGE SMALL-CELL LUNG-CANCER - A CANCER AND LEUKEMIA GROUP-B STUDY, Journal of clinical oncology, 15(11), 1997, pp. 3378-3387
Authors:
PANIWNYK L
PERRY MC
MCWHINNIE WR
HOMER J
GELDER A
Citation: L. Paniwnyk et al., DO THE MEASUREMENTS OF AL-27 AND LI-7 KNIGHT-SHIFTS HAVE ANY ANALYTICAL ROLE IN STUDIES OF FRESHLY PREPARED LITHIUM ALUMINUM-ALLOYS, Polyhedron, 16(17), 1997, pp. 2963-2969
Authors:
LUIKART SD
HERNDON JE
HOLLIS DR
MACDONALD M
MAURER LH
CRAWFORD J
CLAMON GH
WRIGHT J
PERRY MC
OZER H
GREEN MR
Citation: Sd. Luikart et al., PHASE-I TRIAL OF ETOPOSIDE, CARBOPLATIN, AND GM-CSF IN EXTENSIVE SMALL-CELL LUNG-CANCER - A CANCER AND LEUKEMIA GROUP-B STUDY (CALGB-8832), American journal of clinical oncology, 20(1), 1997, pp. 24-30
Authors:
PERRY MC
DESLAURIERS J
ALBAIN KS
CHOI NC
DEPIERRE A
JOHNSTON MR
LACQUET LK
PAYNE DG
PUTNAM JB
SCULIER JP
SHEPHERD FA
Citation: Mc. Perry et al., INDUCTION TREATMENT FOR RESECTABLE NON-SMALL-CELL LUNG-CANCER, Lung cancer, 17, 1997, pp. 15-18
Authors:
NIELL HB
MILLER AA
CLAMON GH
PERRY MC
CRAWFORD J
GREEN MR
Citation: Hb. Niell et al., A PHASE-II STUDY EVALUATING THE EFFICACY OF CARBOPLATIN, ETOPOSIDE, AND PACLITAXEL WITH GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH STAGE-IIIB AND STAGE-IV NONSMALL CELL LUNG-CANCER AND EXTENSIVE SMALL-CELL LUNG-CANCER, Seminars in oncology, 24(4), 1997, pp. 130-134
Authors:
ARTERBURN JB
PERRY MC
Citation: Jb. Arterburn et Mc. Perry, RHENIUM CATALYZED SULFURIZATION OF PHOSPHORUS(III) COMPOUNDS WITH THIIRANES - NEW REAGENTS FOR PHOSPHOROTHIOATE ESTER SYNTHESIS, Tetrahedron letters, 38(44), 1997, pp. 7701-7704
Authors:
DAWN B
PERRY MC
Citation: B. Dawn et Mc. Perry, BILATERAL NON-HODGKINS-LYMPHOMA OF THE BREAST MIMICKING MASTITIS, Southern medical journal, 90(3), 1997, pp. 328-329
Authors:
ARTERBURN JB
PERRY MC
NELSON SL
DIBLE BR
HOLGUIN MS
Citation: Jb. Arterburn et al., RHENIUM-CATALYZED OXIDATION OF THIOLS AND DISULFIDES WITH SULFOXIDES, Journal of the American Chemical Society, 119(39), 1997, pp. 9309-9310
Authors:
PERLOFF M
NORTON L
KORZUN AH
WOOD WC
CAREY RW
GOTTLIEB A
AUST JC
BANK A
SILVER RT
SALEH F
CANELLOS GP
PERRY MC
WEISS RB
HOLLAND JF
Citation: M. Perloff et al., POSTSURGICAL ADJUVANT CHEMOTHERAPY OF STAGE-II BREAST-CARCINOMA WITH OR WITHOUT CROSSOVER TO A NON-CROSS-RESISTANT REGIMEN - A CANCER AND LEUKEMIA GROUP-B STUDY, Journal of clinical oncology, 14(5), 1996, pp. 1589-1598
Authors:
PERRY MC
SIBREL CB
GOUGH GA
Citation: Mc. Perry et al., WETLANDS MITIGATION - PARTNERSHIP BETWEEN AN ELECTRIC-POWER COMPANY AND A FEDERAL WILDLIFE REFUGE, Environmental management, 20(6), 1996, pp. 933-939
Authors:
MITCHELL EP
PERRY MC
LUIKART SD
CIRRINCIONE CT
VANECHO DA
HERNDON JE
MAURER LH
CLAMON G
GREEN MR
Citation: Ep. Mitchell et al., A PHASE I II TRIAL OF ETOPOSIDE AND CISPLATIN IN EXTENSIVE SMALL-CELLLUNG-CANCER - A CANCER AND LEUKEMIA GROUP-B STUDY/, Lung cancer, 15(2), 1996, pp. 215-223
Authors:
BENBADIS SR
PERRY MC
WOLGAMUTH BR
MENDELSON WB
DINNER DS
Citation: Sr. Benbadis et al., THE MULTIPLE SLEEP LATENCY TEST - COMPARISON OF SLEEP ONSET CRITERIA, Sleep, 19(8), 1996, pp. 632-636
Authors:
RAPP JS
PERRY MC
ROTCHE RM
Citation: Js. Rapp et al., EXTENSIVE-STAGE SMALL-CELL LUNG-CANCER - DETERMINING SUITABILITY FOR OUTPATIENT MANAGEMENT OF FEBRILE NEUTROPENIA, Seminars in oncology, 23(2), 1996, pp. 15
Authors:
ARTERBURN JB
PERRY MC
Citation: Jb. Arterburn et Mc. Perry, RHENIUM CATALYZED SULFOXIDE REDUCTION, Tetrahedron letters, 37(44), 1996, pp. 7941-7944
Authors:
SHAHAB N
DOLL DC
PERRY MC
ROLAND W
EVERETT D
Citation: N. Shahab et al., HEMATOLOGICAL MANIFESTATIONS OF EHRLICHIOSIS, Blood, 88(10), 1996, pp. 2861-2861
Authors:
MAGHFOOR I
PERRY MC
DOLL DC
TRUMAN HS
Citation: I. Maghfoor et al., IRON STORES IN CHRONIC MYELOMONOCYTIC LEUKEMIA, Blood, 88(10), 1996, pp. 3554-3554
Authors:
KING PD
PERRY MC
ZANOL K
Citation: Pd. King et al., LYMPHOMA IN THE SETTING OF DERMATITIS-HERPETIFORMIS - ANOTHER CASE, Dermatology, 190(3), 1995, pp. 253-253
Authors:
KING PD
PERRY MC
Citation: Pd. King et Mc. Perry, HEPATOTOXICITY OF CHEMOTHERAPEUTIC AND ONCOLOGIC AGENTS, Gastroenterology clinics of North America, 24(4), 1995, pp. 969